Jump to content

Talk:IQVIA

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
(Redirected from Talk:QuintilesIMS)

Notice: This article WP:A to establish WP:CORP

[edit]

In my opinion, this article either lacks sufficient Attribution that it satisfies the Notability criteria for Organizations and companies, or it may violate the Conflict of interest guideline, or perhaps it is a Copyright violation.

Wikipedia articles must be based on reliable sources to verify any claims of notability. Even though the lack of reliable source attribution in an article is not grounds for deletion in itself, an article with absolutely no sources (or only external links to unreliable ones) suggests to some editors that multiple reliable sources may not, in fact, exist.

Although I am considering tagging this article for deletion according to the Deletion policy, I am nonetheless willing to assist User:Hoverzy (talk · contribs), and other recent contributors to this article, to make some constructive improvements to it ... I do not have time to examine this article in depth at the moment, and it may improve over time, in which case this warning was premature.

Please respond on this Discussion page, instead of on my Talk page, in order to avoid fragmenting the conversation.

To better understand why I have used this template, please read Flag templates for deletion warnings ... I realize that some of the expressed possible concerns may not be appropriate in this case.

triwbe (talk) 16:13, 17 July 2008 (UTC)[reply]

I have removed the [[Category:Flagged articles]] from the message above … it was flagged at least two months ago by Some Other Editor, but the current version looks good to me. Avicennasis @ 06:02, 7 April 2010 (UTC)[reply]

Extremely Important Article

[edit]

In my opinion, It is an extremely important article. it may not be written in the way in which it is needed, but is very important article as it is about one of the giants in clinical research. Dr. Abhijeet Safai (talk) 09:48, 10 October 2012 (UTC)[reply]

IMS merger

[edit]

Some editors have wanted to add this information, followed by my reverts provided with a summary that news is not encyclopedic per WP:NOTNEWS. A merger of this size is important for the clinical research industry, but merger talks sometimes fail before consummation (which is expected in the 2nd half of this year), and this industry has seen that happen before between major players. As I have said in my reverts, this is a news story until it completes, then it is a new fact worthy of being in the article.

Also of note for editing is that this article has been reduced extensively over recent years (mainly by me) due to its previous puffery and self-promotion about Quintiles as the "world's greatest company" or something similar. See the WP guidance on WP:COI (suspected Quintiles employees adding content; review History and first entry on this Talk page above), WP:PEA, WP:SOAP and WP:IINFO, all of which apply to numerous previous reverted entries for this article. I do not claim ownership of this article and would not revert good content sourced with WP:SECONDARY, but haven't seen encyclopedic quality of edits being made, so I continue with surveillance. --Zefr (talk) 22:05, 18 May 2016 (UTC)[reply]

Proposed merge with OneKey

[edit]

Onekey is now an IQVIA product. https://www.iqvia.com/en/locations/united-states/commercial-operations/essential-information/onekey-reference-assets/onekey-web Rogermx (talk) 18:40, 22 September 2018 (UTC)[reply]

What is full form of IQVIA?

[edit]

I am trying to find answer to this question since long but could not find any answer. Maybe this information can be put in this article when someone finds this information with proper sources. Thanks in advance. -- Abhijeet Safai (talk) 06:41, 20 October 2018 (UTC)[reply]

A Google search provided this explanation: "A year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA. Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ taken from Quintiles. However, the latter and newest part of the name - ‘via’ - is representative of “seeking to inspire and ignite real change via a new path forward”, explains Ari Bousbib, chief executive officer of IQVIA." --Zefr (talk) 15:33, 20 October 2018 (UTC)[reply]
Excellent. Thanks a lot. -- Abhijeet Safai (talk) 09:26, 30 October 2018 (UTC)[reply]

ALL CAPS title

[edit]

There are multiple examples of the no all-caps-in-titles rule being enforced. Should be enforced evenly and this page should be Moved to "Iqvia" — Preceding unsigned comment added by 2604:2000:E047:900:5C6D:3E0:85D1:B2F9 (talk) 14:19, 15 November 2018 (UTC)[reply]